Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Active not recruiting 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Glioblastoma 1Breast Neoplasms 1Breast Diseases 1

Interventions

pembrolizumab 374Carboplatin 276Specimen Handling 265Nivolumab 251Magnetic Resonance Spectroscopy 246Cyclophosphamide 240Cisplatin 214Paclitaxel 205Radiotherapy 196Biopsy 172Gemcitabine 155Dexamethasone 150durvalumab 144atezolizumab 125Rituximab 120Doxorubicin 115Bevacizumab 114Lenalidomide 113Ipilimumab 113Radiation 110Pemetrexed 101Etoposide 101Docetaxel 101fludarabine 97venetoclax 95Capecitabine 92Fluorouracil 91Radiosurgery 90Prednisone 89Oxaliplatin 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Genotype × 1 year × Clear all
NCT05006196 2026-05-20

IMOGEN

Perspectum

Active not recruiting
1,030 enrolled
Breast

Breast Diseases, Breast Neoplasms

NCT05120284 2025-08-29

Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

University of Florida

Phase 2 Active not recruiting
40 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡